Jazz Pharmaceuticals: Exec Insider and Funds Supporting Shares in Q3
Insiders are generally long-term investors due to restriction in making short-term profits. In contrast, wealth management institutions always have short-term investment. Wall St. Watchdog reveals information regarding the insiders and institutions which recently increased stock shares of Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ).
SEC data indicate these insiders have bought Jazz Pharmaceuticals, Inc.’s stock since 06/30/2011:
- Falberg Kathryn E: act as SVP and CFO. On 11/11/2011, bought 3,000 shares, worth $112,100.
SEC data indicate that these institutions significantly increased their stock shares of Jazz Pharmaceuticals, Inc. in Q3 2011:
- LORD ABBETT & CO LLC: On 06/30/2011, held 0 shares. On 09/30/2011, held 606,158 shares, worth $25,155,557.
- MORGAN STANLEY: On 06/30/2011, held 0 shares. On 09/30/2011, held 316,980 shares, worth $13,154,670.
- DRIEHAUS CAPITAL MANAGEMENT LLC: On 06/30/2011, held 0 shares. On 09/30/2011, held 274,009 shares, worth $11,371,374.
- INVESTEC ASSET MANAGEMENT LTD: On 06/30/2011, held 0 shares. On 09/30/2011, held 195,001 shares, worth $8,092,542.
- COLUMBUS CIRCLE INVESTORS: On 06/30/2011, held 0 shares. On 09/30/2011, held 130,754 shares, worth $5,426,291.
About the company: Jazz Pharmaceuticals, Inc. develops and markets treatments for neurological and psychiatric conditions. The Company produces treatments for cataplexy, excessive daytime sleepiness, and ethylene glycol and methanol poisoning in humans.
Competitors to Watch: Cephalon, Inc. (NASDAQ:CEPH), Forest Laboratories, Inc. (NYSE:FRX), Transcept Pharmaceuticals, Inc. (NASDAQ:TSPT), Pfizer Inc. (NYSE:PFE), GlaxoSmithKline plc (NYSE:GSK), Eli Lilly & Co. (NYSE:LLY), Abbott Laboratories (NYSE:ABT), Caraco Pharmaceutical Laboratories Ltd. (AMEX:CPD), Watson Pharmaceuticals, Inc. (NYSE:WPI), and McKesson Corporation (NYSE:MCK).
(Note: Data regarding Jazz Pharmaceuticals, Inc.’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)
Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>